Carvolix: Results of the Combined General Meeting of January 2026

On January 30, 2026, Carvolix, formerly Affluent Medical, held its Combined General Meeting in Aix-en-Provence. The MedTech company presented the voting results for several resolutions. Under the chairmanship of Mr. Michel Thérin, the shareholders approved the change of company name and ratified the appointment of Mr. Alain Chevallier as a member of the Board of Directors.

The resolutions on delegations of authority for financial operations were unanimously adopted. Shareholders voted 98.37% in favor of changing the company name. The delegations of authority for the capital increase also received full support. The turnout reached 92.3%, with 52,614,168 votes cast on the items submitted to the General Meeting.